Ibritumomab Intravenous and Kionex (Sodium Polystyrene Sulfonate Powder)
Determining the interaction of Ibritumomab Intravenous and Kionex (Sodium Polystyrene Sulfonate Powder) and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ibritumomab
Brand name: Y-90 Zevalin, In-111 Zevalin
Synonyms: Ibritumomab, Ibritumomab Tiuxetan
Generic Name: sodium polystyrene sulfonate
Brand name: Kalexate, Kayexalate, Kionex
Synonyms: Kionex
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ibritumomab Intravenous-Kionex (Sodium Polystyrene Sulfonate Suspension)
- Ibritumomab Intravenous-Kirkland Signature Sleep Aid
- Ibritumomab Intravenous-Kirklands Childrens Aller-Tec
- Ibritumomab Intravenous-Kirklands Signature Aller-Tec
- Ibritumomab Intravenous-Kisqali
- Ibritumomab Intravenous-Kisqali (200 MG Dose)
- Kionex (Sodium Polystyrene Sulfonate Powder)-Ibritumomab Tiuxetan
- Kionex (Sodium Polystyrene Sulfonate Powder)-Ibrutinib
- Kionex (Sodium Polystyrene Sulfonate Powder)-Ibrutinib Capsules
- Kionex (Sodium Polystyrene Sulfonate Powder)-Ibrutinib Tablets
- Kionex (Sodium Polystyrene Sulfonate Powder)-Ibu
- Kionex (Sodium Polystyrene Sulfonate Powder)-IBU Tablets